Found: 7
Select item for more details and to access through your institution.
Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 1, p. 135, doi. 10.1111/apt.15784
- By:
- Publication type:
- Article
Effectiveness of Third-Class Biologic Treatment in Crohn's Disease: A Multi-Center Retrospective Cohort Study.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 13, p. 2914, doi. 10.3390/jcm10132914
- By:
- Publication type:
- Article
New insights in acetaminophen toxicity: HMGB1 contributes by itself to amplify hepatocyte necrosis in vitro through the TLR4-TRIF-RIPK3 axis.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-61270-1
- By:
- Publication type:
- Article
New approach to determine the healthy immune variations by combining clustering methods.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-88272-x
- By:
- Publication type:
- Article
Introduction of Subcutaneous Infliximab CT-P13 and Vedolizumab in Clinical Practice: A Multi-Stakeholder Position Statement Highlighting the Need for Post-Marketing Studies.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 7, p. 1059, doi. 10.1093/ecco-jcc/jjac009
- By:
- Publication type:
- Article
Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn's Disease Who Failed Biologic Therapies: A National Cohort Study.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 11, p. 1401, doi. 10.1093/ecco-jcc/jjz080
- By:
- Publication type:
- Article
Variability of Faecal Calprotectin in Inflammatory Bowel Disease Patients: An Observational Case-control Study.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 11, p. 1372, doi. 10.1093/ecco-jcc/jjz069
- By:
- Publication type:
- Article